|
Name |
1,2-Octadecanediol
|
| Molecular Formula | C18H38O2 | |
| IUPAC Name* |
octadecane-1,2-diol
|
|
| SMILES |
CCCCCCCCCCCCCCCCC(CO)O
|
|
| InChI |
InChI=1S/C18H38O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-18(20)17-19/h18-20H,2-17H2,1H3
|
|
| InChIKey |
XWAMHGPDZOVVND-UHFFFAOYSA-N
|
|
| Synonyms |
1,2-Octadecanediol; Octadecane-1,2-diol; Stearyl glycol; 1,2-Dihydroxyoctadecane; 20294-76-2; 9J9GD77RJI; NSC-71534; O-Hexadecylethanediol; UNII-9J9GD77RJI; octadecylene glycol; EINECS 243-711-3; NSC 71534; AI3-14194; NCIOpen2_003464; SCHEMBL439709; STEARYL GLYCOL [INCI]; CHEBI:84956; DTXSID101021743; NSC71534; FT-0605124; Q27158218
|
|
| CAS | 20294-76-2 | |
| PubChem CID | 89314 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 286.5 | ALogp: | 7.2 |
| HBD: | 2 | HBA: | 2 |
| Rotatable Bonds: | 16 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 40.5 | Aromatic Rings: | 0 |
| Heavy Atoms: | 20 | QED Weighted: | 0.368 |
| Caco-2 Permeability: | -4.79 | MDCK Permeability: | 0.00002340 |
| Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.292 |
| Human Intestinal Absorption (HIA): | 0.009 | 20% Bioavailability (F20%): | 0.306 |
| 30% Bioavailability (F30%): | 0.942 |
| Blood-Brain-Barrier Penetration (BBB): | 0.061 | Plasma Protein Binding (PPB): | 97.70% |
| Volume Distribution (VD): | 1.101 | Fu: | 1.60% |
| CYP1A2-inhibitor: | 0.336 | CYP1A2-substrate: | 0.193 |
| CYP2C19-inhibitor: | 0.276 | CYP2C19-substrate: | 0.056 |
| CYP2C9-inhibitor: | 0.144 | CYP2C9-substrate: | 0.939 |
| CYP2D6-inhibitor: | 0.016 | CYP2D6-substrate: | 0.063 |
| CYP3A4-inhibitor: | 0.164 | CYP3A4-substrate: | 0.041 |
| Clearance (CL): | 6.169 | Half-life (T1/2): | 0.242 |
| hERG Blockers: | 0.194 | Human Hepatotoxicity (H-HT): | 0.013 |
| Drug-inuced Liver Injury (DILI): | 0.025 | AMES Toxicity: | 0.009 |
| Rat Oral Acute Toxicity: | 0.013 | Maximum Recommended Daily Dose: | 0.015 |
| Skin Sensitization: | 0.937 | Carcinogencity: | 0.034 |
| Eye Corrosion: | 0.447 | Eye Irritation: | 0.968 |
| Respiratory Toxicity: | 0.457 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC000082 | ![]() |
0.767 | D07ILQ | ![]() |
0.625 | ||
| ENC000486 | ![]() |
0.758 | D00AOJ | ![]() |
0.610 | ||
| ENC000789 | ![]() |
0.758 | D0Z5SM | ![]() |
0.521 | ||
| ENC000666 | ![]() |
0.746 | D00FGR | ![]() |
0.517 | ||
| ENC000488 | ![]() |
0.734 | D0O1PH | ![]() |
0.482 | ||
| ENC000284 | ![]() |
0.723 | D05ATI | ![]() |
0.444 | ||
| ENC000484 | ![]() |
0.718 | D0P1RL | ![]() |
0.391 | ||
| ENC000426 | ![]() |
0.717 | D00STJ | ![]() |
0.390 | ||
| ENC000515 | ![]() |
0.714 | D0T9TJ | ![]() |
0.372 | ||
| ENC000380 | ![]() |
0.710 | D0XN8C | ![]() |
0.318 | ||